How sex chromosomes influence brain immune cells in Alzheimer's and aging
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
This research looks at whether differences in X and Y chromosomes change how brain immune cells react during aging and Alzheimer's, which might explain why men and women experience the illness differently.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11180367 on NIH RePORTER |
What this research studies
From a patient's perspective, researchers are using well-established Alzheimer's mouse models that carry human disease genes to study immune cells in the hippocampus. They will compare animals with XX versus XY chromosome complements to see how sex chromosomes, apart from hormones, change microglial activation as animals age or develop Alzheimer-like brain changes. The team will use cellular and molecular methods to study X-linked regulators such as histone modifiers and link those findings to genes implicated by human Alzheimer's genetics. Although lab-based, the goal is to reveal biological differences that could guide future sex-specific therapies or better-targeted clinical trials.
Who could benefit from this research
Good fit: This project does not enroll patients directly, but its findings are most relevant to older adults and people diagnosed with Alzheimer's disease.
Not a fit: People without Alzheimer's or those seeking immediate treatment options are unlikely to get direct benefit from this laboratory-focused research in the near term.
Why it matters
Potential benefit: If successful, this work could identify sex-specific molecular targets in brain immune cells that lead to more effective, personalized treatments for Alzheimer's.
How similar studies have performed: Previous human genetics and animal studies have linked microglial genes to Alzheimer's risk, but directly linking sex chromosome effects on microglia is a newer, exploratory direction.
Where this research is happening
Oklahoma City, United States
- Oklahoma Medical Research Foundation — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Ocanas, Sarah Renee — Oklahoma Medical Research Foundation
- Study coordinator: Ocanas, Sarah Renee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.